Underutilization of the CROSS Regimen Among US Radiation Oncologists: A National Survey of Practice Patterns. (Record no. 29013316)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01425 a2200421 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518005120.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201811s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1791-7530 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.21873/anticanres.12996 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Elliott, David A |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20181113 |
| 245 00 - TITLE STATEMENT | |
| Title | Underutilization of the CROSS Regimen Among US Radiation Oncologists: A National Survey of Practice Patterns. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Anticancer research |
| Date of publication, distribution, etc. | Nov 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 6375-6379 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carboplatin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chemoradiotherapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clinical Trials as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Esophageal Neoplasms |
| General subdivision | therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoadjuvant Therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Paclitaxel |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Practice Patterns, Physicians' |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Radiation Oncologists |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Radiotherapy Dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Surveys and Questionnaires |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rana, Shushan R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nabavizadeh, Nima |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chen, Yiyi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kusano, Aaron |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Holland, John M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mitin, Timur |
| 773 0# - HOST ITEM ENTRY | |
| Title | Anticancer research |
| Related parts | vol. 38 |
| -- | no. 11 |
| -- | p. 6375-6379 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.21873/anticanres.12996">https://doi.org/10.21873/anticanres.12996</a> |
| Public note | Available from publisher's website |
No items available.